Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration
- PMID: 9486113
- PMCID: PMC1363801
- DOI: 10.1046/j.1365-2567.1997.00360.x
Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration
Abstract
The induction phase of contact sensitization is associated with the movement of epidermal Langerhans cells (LC) from the skin and their migration, via afferent lymphatics, to draining lymph nodes where they accumulate as immunostimulatory dendritic cells (DC). It has been demonstrated previously that tumour necrosis factor-alpha (TNF-alpha) provides an important signal for LC migration and that in the absence of this cytokine, movement of LC from the epidermis to regional lymph nodes is inhibited. Recent evidence indicates that interleukin-1 beta (IL-1 beta), a cytokine produced in murine epidermis exclusively by LC, may also play a role in LC migration. The purpose of the investigations described here was to clarify, using relevant neutralizing anti-cytokine antibodies, the contributions made by TNF-alpha and IL-1 beta to the migration of LC from the epidermis. It was found that like anti-TNF-alpha, anti-IL-1 beta administered systemically to mice (by intraperitoneal injection), prior to skin sensitization with the contact allergen oxazolone, resulted in a marked inhibition of DC accumulation in draining lymph nodes. It was shown also that anti-IL-1 beta inhibited TNF-alpha-induced LC migration and DC accumulation and that; in similar fashion, the stimulation of LC migration and DC accumulation induced by IL-1 beta was compromised by prior treatment with anti-TNF-alpha. Based upon these data it is proposed that the stimulation of LC migration in response to skin sensitization requires the receipt by LC of two independent signals, one provided by TNF-alpha and the other by IL-1 beta. Morphological analyses of LC in epidermal sheets prepared from animals exposed to these cytokines with or without prior systemic treatment with anti-cytokine antibody suggested that the changes induced in LC by TNF-alpha and IL-1 beta may include the altered expression of adhesion molecules and acquisition of the ability to interact with and pass through the basement membrane.
Similar articles
-
Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism.Immunology. 2001 Mar;102(3):323-30. doi: 10.1046/j.1365-2567.2001.01187.x. Immunology. 2001. PMID: 11298831 Free PMC article.
-
Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization.Immunology. 1995 Jan;84(1):31-5. Immunology. 1995. PMID: 7890303 Free PMC article.
-
Differential regulation of epidermal langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses.Toxicol Appl Pharmacol. 2002 Jul 15;182(2):126-35. doi: 10.1006/taap.2002.9442. Toxicol Appl Pharmacol. 2002. PMID: 12140176
-
Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha).J Invest Dermatol. 1992 Nov;99(5):48S-50S. doi: 10.1111/1523-1747.ep12668986. J Invest Dermatol. 1992. PMID: 1431209 Review.
-
Langerhans cell migration.Clin Exp Dermatol. 2000 Jul;25(5):413-8. doi: 10.1046/j.1365-2230.2000.00678.x. Clin Exp Dermatol. 2000. PMID: 11012599 Review.
Cited by
-
Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth.J Clin Invest. 2000 May;105(10):1383-93. doi: 10.1172/JCI7548. J Clin Invest. 2000. PMID: 10811846 Free PMC article.
-
Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes.J Exp Med. 2008 Nov 24;205(12):2839-50. doi: 10.1084/jem.20081430. Epub 2008 Nov 3. J Exp Med. 2008. PMID: 18981237 Free PMC article.
-
IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin.Clin Exp Immunol. 2003 May;132(2):352-9. doi: 10.1046/j.1365-2249.2003.02146.x. Clin Exp Immunol. 2003. PMID: 12699428 Free PMC article. Clinical Trial.
-
Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells.Immunology. 2001 Dec;104(4):462-7. doi: 10.1046/j.1365-2567.2001.01333.x. Immunology. 2001. PMID: 11899433 Free PMC article.
-
The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier.Front Immunol. 2021 Dec 23;12:808012. doi: 10.3389/fimmu.2021.808012. eCollection 2021. Front Immunol. 2021. PMID: 35003136 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources